On June 7, 2022, Pinetree Therapeutics Inc. closed the transaction. The company has amended the terms of the transaction. The company now received $23,500,000 in the transaction.

The transaction included participation from InterVest Co., Ltd., SK Securities Co., Ltd., DSC Investment Inc., J Curve Investment, Samho Green Investment, Inc. and SJ Investment Partners Co.,Ltd.